Form N-CSRS - Certified Shareholder Report, Semi-Annual:
SEC Accession No. 0001104659-24-069987
Filing Date
2024-06-10
Accepted
2024-06-10 14:34:55
Documents
11
Period of Report
2024-03-31
Effectiveness Date
2024-06-10

Document Format Files

Seq Description Document Type Size
1 N-CSRS tm2416006d11_ncsrs.htm N-CSRS 779808
2 EXHIBIT 99.CERT tm2416006d11_ex99-cert.htm EX-99.CERT 19727
3 EXHIBIT 99.906CERT tm2416006d11_ex99-906cert.htm EX-99.906CERT 6915
4 EXHIBIT 99.(C)(1) tm2416006d11_ex99-xcx1.htm EX-99.(C)(1) 100830
5 EXHIBIT 99.(C)(2) tm2416006d11_ex99-xcx2.htm EX-99.(C)(2) 83225
6 GRAPHIC tm2416006d11_ex-99xcx1img01.jpg GRAPHIC 3692
7 GRAPHIC tm2416006d11_ex-99xcx2img01.jpg GRAPHIC 3756
8 GRAPHIC tm2416006d11hqlreporti001.gif GRAPHIC 348585
9 GRAPHIC tm2416006d11hqlreporti002.gif GRAPHIC 619
10 GRAPHIC tm2416006d11hqlreporti003.jpg GRAPHIC 16938
11 GRAPHIC tm2416006d11hqlreporti004.jpg GRAPHIC 7756
  Complete submission text file 0001104659-24-069987.txt   1517629
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CSRS | Act: 40 | File No.: 811-06565 | Film No.: 241032324